Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Posted on April 1, 2021

Will intranasal vaccines confer sterilising immunity?

Developed by Washington University School of Medicine in St. Louis, the vaccine has been licensed to Bharat Biotech to carry out human clinical trials, manufacture the vaccine and distribute them…

Continue Reading
Posted on March 26, 2021March 26, 2021

Achieving vaccine equity by making comorbidities redundant for those above 45 years

By following the U.K. model of vaccinating people based on age bands rather than focussing on comorbidities, millions of people would become eligible to receive the vaccine and be fully…

Continue Reading
Posted on March 20, 2021

Should Covaxin trial continue till 130 cases are recorded?

According to details posted on the clinical trial registry, the company had planned to “continue the phase-3 trial until 130 study participants developed PCR-confirmed symptomatic COVID-19 disease during follow-up beginning…

Continue Reading
Posted on March 13, 2021

Will adenovirus antibodies reduce the efficacy of vector vaccines?

While it is unclear if pre-existing antibodies to adenovirus vector will affect vaccine efficacy, it is possible that repeated vaccination using adenovirus-based vaccine either as a booster or as annual vaccination, if the need arises, will result in reduced efficacy due to vector immunity.

Continue Reading
Posted on March 6, 2021March 7, 2021

As cases spike in a few States, what is causing a decline in Kerala?

Even as recently as March 6, March 4, March 3, March 2 and March 1 the Health Ministry mischievously implicated Kerala for the surge in cases when it included Kerala…

Continue Reading
Posted on March 5, 2021March 5, 2021

Covaxin should no longer be available in ‘clinical trial mode’

The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the second dose. The interim analysis undertaken at the first endpoint…

Continue Reading
Posted on March 3, 2021March 3, 2021

IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected

The results have been posted on medRxiv preprint server. Preprints are yet to be peer-reviewed and published in scientific journals. Though measurements were made only till day 28 after the…

Continue Reading
Posted on March 1, 2021March 1, 2021

Doctors say comorbidities list for COVID-19 vaccination is highly restrictive

“The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been left out,” says Dr. Gagandeep Kang, Professor of Microbiology at…

Continue Reading

Posts navigation

Previous Page Page 1 Page 2 Page 3 … Page 247 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,784 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • How can India contain the second wave? April 16, 2021
  • In a major shift, India fast-tracks restricted use approval for vaccines developed in other countries April 13, 2021
  • COVID-19: Protection against reinfection may last only for months April 11, 2021
  • India will add four million more cases by May 1, says Giridhara Babu April 10, 2021
  • 180 deaths following COVID-19 vaccination reported in India April 9, 2021

Most Read Posts

  • How can India contain the second wave?
  • IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected
  • COVID-19: Protection against reinfection may last only for months
  • No correlation between Ct values of PCR test and COVID-19 severity
  • Sadhguru Jaggi Vasudev, stop spreading vaccine misinformation
  • In a major shift, India fast-tracks restricted use approval for vaccines developed in other countries
  • UGC’s revised white list has 71 active predatory journals
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,784 other followers

Archives

Cancel

 
Loading Comments...
Comment
    ×